July 2009 · Vol. 21, No. 07Women given a diagnosis of CIN face an elevated risk of recurrence
The likelihood of recurrence depends on the grade of CIN, the treatment used, and the woman’s age.
Janelle
YatesSenior Editor
Women who have been treated for cervical intraepithelial neoplasia (CIN) face an elevated risk of recurrence and invasive cervical cancer. That’s the conclusion drawn from a recent population-based study of 37,142 women who were treated for CIN 1, 2, or 3 between 1986 and 2000.
In the first 6 years after treatment, the cumulative rate of CIN 2 or 3 in this group was:
|
